Senators Urge USPS to Maintain Cannabis Mailing Ban
Federal officials are pushing to block mail-order cannabis despite some states attempting to authorize home delivery.
Updated on Oct. 29, 2026 in Substance Abuse
Live Poll
Should the U.S. Postal Service allow the shipment of medical cannabis to patients?
U.S. Senators James Lankford and Ted Budd have urged the U.S. Postal Service to maintain its ban on shipping cannabis, directly challenging a recent move by Georgia state regulators. The request comes as state-level entities seek to improve medication access for homebound patients.
Why it matters
The dispute highlights the ongoing friction between federal postal regulations and shifting state-level medical cannabis policies. For patients, this creates uncertainty regarding the future of home delivery services for state-licensed medical products.
Federal policies currently allow for the mailing of hemp products containing 0.3% THC or less, while maintaining a strict ban on all other cannabis forms. It remains unknown if federal postal rules will be updated to align with the Attorney General's April 2026 reclassification of medical cannabis.
The players
James Lankford
U.S. Senator from Oklahoma, a state that previously licensed 9,178 grow operations.
Ted Budd
U.S. Senator from North Carolina concerned with potential interstate drug movement.
David Steiner
Postmaster General tasked with overseeing USPS mailing policies and federal compliance.
Georgia Medical Cannabis Commission
State regulatory body that recently authorized the delivery of medical cannabis via mail.
The details
The conflict centers on whether state-licensed medical cannabis should be transportable through the U.S. mail system. While the Georgia Medical Cannabis Commission voted in August 2026 to allow such deliveries to improve patient access, Senators argue that state licensing schemes lack the reliability to prevent illegal cross-state drug movement. Current postal regulations allow for the shipment of hemp, but explicitly exclude products exceeding the 0.3% THC concentration limit.
Timeline
April 2026: The U.S. Attorney General reclassified medical cannabis as a Schedule III substance.
August 2026: The Georgia Medical Cannabis Commission voted to permit cannabis mail delivery.
October 27, 2026: Senators Lankford and Budd requested that the USPS maintain its current mailing ban.
Health Landscape
The debate reflects the tension between federal Controlled Substances Act scheduling and the expanding reach of state-authorized medical treatments. This struggle marks a significant departure from established postal norms as states attempt to modernize drug delivery for homebound populations.
Patients who rely on home delivery for medical cannabis should consult their local dispensary or healthcare provider to confirm current, legal delivery methods. It is worth tracking whether your specific state regulators have established valid shipping protocols that comply with federal postal standards.
The takeaway
The federal ban on mailing cannabis remains in place, creating significant legal barriers for home delivery programs. Patients should continue to prioritize secure, in-person access through licensed dispensaries until clear federal guidance or policy changes are confirmed.
Further reading
For more on the current regulations affecting medical access, visit Substance Abuse.
Source note: This article includes information reported by Cannabis Business Times.
Live Poll
Should the U.S. Postal Service allow the shipment of medical cannabis to patients?
